Navigation Links
A few circulating cancer cells could cue risk of metastases
Date:6/9/2014

St. Louis, Mo. (June 9, 2014) A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

Metastasis accounts for an estimated 90 percent of cancer deaths. For decades, researchers tried to develop a way to gauge a cancer's risk of metastasizing from a blood samplethe long-sought-after liquid biopsy. Today there are numerous methods available to isolate lone cells. Novel methods recently used to study those cells are radioluminescence microscopy, which combines nuclear medicine, optical imaging and single-cell autoradiography (SCAR), used to localize the micro-distribution of radioactive substances in a single cell in order to image a particular physiological process, such as a receptor expressing genetic information or an enzyme involved in cellular metabolism.

"We are now starting to study the properties of these lone cancer cells, which could be predictive of different disease states and that understanding could help guide therapy decisions," said Laura S. Sasportas, a principal researcher and PhD candidate in the Gambhir Lab in the department of bioengineering at Stanford University in Stanford, Calif. "The great potential of looking at circulating tumor cells (CTCs) has been limited mainly by their extreme rarity. For example, in the case of breast cancer, CTCs are estimated to be in the order of a few to a few hundred cells among billions of blood cells in a typical 7.5 milliliter blood sample from a cancer patient. In the past decade, however, CTC research has been booming due to the development of exciting new technologies that can sensitively detect and harvest those very rare cells from patient's blood."

For this study, researchers took breast cancer cells isolated from the blood of small animal models and imaged them using radioluminescence microscopy and SCAR along with a common molecular imaging radiotracer called F-18 fluorodeoxyglucose (FDG). The latter mirrors the exchange of energy in the presence of glucose in order to target the few hyper-metabolic cancer cells within these blood samples. Results of the research showed that less than three percent of CTCs in the sample indicated increased cellular metabolism compared to the parent cancer cell line. Researchers are not yet sure if this indicates an aggressive cancer cell or not. Further research and validation in clinical trials is needed to strengthen the theory.

"We hypothesize that the unexplored metabolic characterization of CTCs could provide valuable information for disease monitoring," said Sasportas. "By evaluating the glucose metabolism of CTCs with F-18 FDG, we could better manage the care of cancer patients by improving therapy selection and therefore avoiding unnecessary treatment."

Cancer remains a top cause of death across the globe. It was thought to account for approximately 8.2 million deaths in 2012, according to current World Health Organizations statistics. Lung, liver, stomach, colorectal and breast cancer are associated with the highest mortality.


'/>"/>

Contact: Kimberly Brown
kbrown@snmmi.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. New technology using florescent proteins tracks cancer cells circulating in the blood
2. NCCS and Clearbridge Biomedics open the regions first circulating tumor cell center
3. Circulating tumor cells in blood can predict a patients response to chemotherapy
4. New research finds flu shot effective regardless of circulating flu strain
5. Sous Vide Circulating Bath Systems Enable Chefs to Achieve Perfect Results
6. Detecting circulating tumor cells
7. New technology allows scientists to capture and preserve cancer cells circulating in the bloodstream
8. Capturing circulating cancer cells could provide insights into how disease spreads
9. Molecular imaging finds novel way to knock down breast cancer
10. PSMA-based imaging traces even treatment-resistant prostate cancer
11. Molecular breast imaging protocol unmasks more cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: